ACT 2023 Annual Meeting
→ Booth #333 Spotlight on difficult-to-test samples and in vitro quantitative potency assessment as an alternative to the Local Lymph Node Assay Come meet us at booth #333 and join our […]
→ Booth #333 Spotlight on difficult-to-test samples and in vitro quantitative potency assessment as an alternative to the Local Lymph Node Assay Come meet us at booth #333 and join our […]
Presentation The GARD®skin Medical Device assay for assessing the skin sensitizing potential of medical devices: A case study on the use of in vitro data in the biological evaluation for […]
Join our upcoming free webinar to explore the effective utilization of in vitro methods for safety assessment of materials during product development of Medical Devices. We will discuss recent advancements […]
Join our upcoming webinar to explore the recent advancement in GARD® for Skin Sensitization assessment, with a specific focus on substances that fall outside the applicability domains of the conventional […]
Booth #732 Discuss your testing needs with us Exhibitor-Hosted Session Expert round table on NAMs and industry trends Tuesday, 12 Mar | 9:00 am-10:00 am Posters Spotlight on PoD, […]
Spotlight on Applicability Domain, Quantitative Potency Assessment and Medical Devices In case you missed SenzaGen’s poster presentations and scientific session at this year’s SOT, we are pleased to offer you a new opportunity to […]
Program 'Introduction to GARDskin (OECD TG 442E) for evaluation of skin sensitization hazard with dose-response option for quantitative risk assessment' Date: 30/05 Session 1: Safety: from irritation to sensitization Presenter: […]
Come meet us at booth #22 and join our presentations to hear the latest news about GARD® and how the assays are used to fill data gaps for skin sensitizing […]
Meet us in Liverpool at the the 11th meeting of Immunotoxicology & Chemical Allergy (ITCASS) and the 30th meeting of European Research Group on Experimental Contact Dermatitis (ERGECD).
Spotlight on in vitro quantitative assessment of skin sensitizing potency. Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency. This session […]